New pediatric guidelines are out!
The 2025 ESAIC and ESPA guidelines on neuromuscular block in anaesthetised children states "Use EMG- rather than AMG-based neuromuscular monitoring".
“Senzime doesn’t just deliver a cutting-edge product, they deliver ongoing support.
They listen to the end users using the technology and consistently show up to ensure it performs as intended in real-world practice.”
- Erik Wroblewski, Anesthesia Tech Manager, Froedtert & the Medical College of Wisconsin
Bringing the next-generation TetraGraph into our community hospital has transformed how we manage neuromuscular block.
It has improved patient safety, standardized our practices, and reduced our annual drug spend by more than $100,000.
- Dr. Aaron Persinger
Anesthesiologist, Boulder Valley Anesthesiology Medical Director, UCHealth Broomfield Anesthesiology Medical Director, Pre-Anesthesia Testing Clinic, UCHealth Broomfield
40
109
45
5,125
Supporting you from start to finish
We provide more than cutting-edge technology. Our commitment extends to helping you excel with resources and support tailored to your needs.
Learn about the latest clinical guidelines, get started with quantitative TOF monitoring, and access valuable insights to improve patient outcomes.
Senzime is a leading medical device company at the forefront of a changing healthcare market, driven by new clinical guidelines and emerging technologies.